Foundation Fighting Blindness Celebrates 15th Year of VisionWalk with New Branding
09. Januar 2020 14:00 ET
|
Foundation Fighting Blindness
Columbia, MD, Jan. 09, 2020 (GLOBE NEWSWIRE) -- The Foundation Fighting Blindness launches 2020 with a bold, new logo and branding for its signature fundraising event, VisionWalk. VisionWalk...
Foundation Fighting Blindness Launches Natural History Study for People with Retinitis Pigmentosa Caused by EYS Gene Mutations
27. November 2019 07:00 ET
|
Foundation Fighting Blindness
Columbia, MD, Nov. 27, 2019 (GLOBE NEWSWIRE) -- The Foundation Fighting Blindness has launched a natural history study (NCT04127006) for people with retinitis pigmentosa (RP) caused by mutations in...
Blueprint Genetics, InformedDNA and the Foundation Fighting Blindness launch an open access program for patients with inherited retinal disease in the United States
02. Oktober 2019 07:00 ET
|
Foundation Fighting Blindness
COLUMBIA, Maryland, Oct. 02, 2019 (GLOBE NEWSWIRE) -- Blueprint Genetics, InformedDNA and the Foundation Fighting Blindness have announced that beginning in October 2019, a new open-access program...
Foundation Fighting Blindness Appoints Judy Taylor Vice President, Development
15. Juli 2019 10:00 ET
|
Foundation Fighting Blindness
Columbia, MD, July 15, 2019 (GLOBE NEWSWIRE) -- The Foundation Fighting Blindness, the world’s leading private funding source for retinal degenerative disease research, has announced that it has...
Foundation Fighting Blindness Clinical Research Institute to Launch Natural History Study for Stargardt Disease to Help Prepare for Clinical Trials
13. März 2013 15:07 ET
|
Foundation Fighting Blindness
COLUMBIA, Md., March 13, 2013 (GLOBE NEWSWIRE) -- The Foundation Fighting Blindness Clinical Research Institute is launching a natural history study of people affected by Stargardt disease, a genetic...
Foundation Fighting Blindness Announces $2.4 Million in Funding for Eight New Sight-Saving Research Projects
21. August 2012 17:15 ET
|
Foundation Fighting Blindness
OWINGS MILLS, Md. and COLUMBIA, Md., Aug. 21, 2012 (GLOBE NEWSWIRE) -- The Foundation Fighting Blindness announces an investment of $2.4 million in eight promising research projects aimed at providing...
Foundation Fighting Blindness and RetroSense Therapeutics Make Progress Toward First-Ever Clinical Trial for Optogenetic Gene Therapy Treatment
25. Mai 2012 08:58 ET
|
Foundation Fighting Blindness
OWINGS MILLS, Md., May 25, 2012 (GLOBE NEWSWIRE) -- After a productive meeting this week with the U.S. Food and Drug Administration (FDA), the Foundation Fighting Blindness acknowledges a clearer path...
Foundation Fighting Blindness Invests $8.25 Million in Six Gene Therapy Research Projects Poised for Clinical Trials
31. Oktober 2011 13:05 ET
|
Foundation Fighting Blindness
COLUMBIA, Md., Oct. 31, 2011 (GLOBE NEWSWIRE) -- The Foundation Fighting Blindness, a national nonprofit dedicated to advancing sight-saving research, announces an $8.25 million investment in six new...